Didn’t find what you’re looking for?Email Lauren Carmody to suggest a topic.
According to the World Health Organization, tuberculosis is the second greatest killer worldwide due to a singular infectious agent (a bacterium called Mycobacterium tuberculosis).
Based in Storrs, Connecticut, a startup called Dura Biotech is offering hope to high-risk cardiac patients who need valve replacement surgery.
Three years after CI’s investment, Nufern was acquired by ROFIN-SINAR Technologies.
CiDRA has grown to 120 employees and has been able to sell a number of divisions.
Achillion completed a successful IPO that yielded $55.3 million in net proceeds, and today, the company has three major products in development for the treatment of infectious diseases.
Premise was acquired by Georgia-based Eclipsys Corporation for $38.5 million.